Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 68, 2008 - Issue 8
Submit an article Journal homepage
393
Views
76
CrossRef citations to date
0
Altmetric
Original Article

Indoleamine 2,3‐dioxygenase activity associates with cardiovascular risk factors: The Health 2000 study

P. Niinisalo Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, University of Tampere, Medical School, Tampere, Finland
,
A. Raitala Department of Microbiology and Immunology, University of Tampere, Medical School, Tampere, Finland
,
M. Pertovaara Department of Microbiology and Immunology, University of Tampere, Medical School, Tampere, Finland; Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
,
S. S. Oja The Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland; Department of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere, Finland
,
T. Lehtimäki Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital and the Medical School, University of Tampere, Tampere, Finland
,
M. Kähönen Department of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere, Finland
,
A. Reunanen Department of Health and Functional Capacity, National Public Health Institute, Helsinki/Turku, Finland
,
A. Jula Department of Health and Functional Capacity, National Public Health Institute, Helsinki/Turku, Finland
,
L. Moilanen Department of Medicine, Kuopio University Hospital, Kuopio, Finland
,
Y. A. Kesäniemi Department of Medicine and Biocenter Oulu, University of Oulu, Oulu, Finland
,
M. S. Nieminen Department of Medicine, University of Helsinki, Helsinki, Finland
&
M. Hurme Department of Microbiology and Immunology, University of Tampere, Medical School, Tampere, Finland; The Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland
 show all
Pages 767-770 | Received 03 Apr 2008, Accepted 01 Jun 2008, Published online: 08 Jul 2009

Citations (76)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Zheng Wang & Qibin Qi. (2019) Gut Microbial Metabolites Associated With HIV Infection. Future Virology 14:5, pages 335-347.
Read now
Tiziana Di Pucchio, Silvio Danese, Raimondo De Cristofaro & Sergio Rutella. (2010) Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds. Expert Opinion on Therapeutic Patents 20:2, pages 229-250.
Read now
Petri Niinisalo, Niku Oksala, Mari Levula, Markku Pelto-Huikko, Otso Järvinen, Juha-Pekka Salenius, Leena Kytömäki, Juhani T. Soini, Mika Kähönen, Reijo Laaksonen, Mikko Hurme & Terho Lehtimäki. (2010) Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere Vascular Study. Annals of Medicine 42:1, pages 55-63.
Read now
Helge Røsjø & Torbjørn Omland. (2008) New cardiovascular risk markers: The race is on, but are there any winners?. Scandinavian Journal of Clinical and Laboratory Investigation 68:8, pages 673-677.
Read now

Articles from other publishers (72)

Chad Stroope, Felix Sebastian Nettersheim, Brian Coon, Alexandra C. Finney, Martin A. Schwartz, Klaus Ley, Oren Rom & Arif YurdagulJr.Jr.. (2024) Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities. Nature Metabolism 6:4, pages 617-638.
Crossref
Atieh Mirzababaei, Maryam Mahmoodi, Abbasali Keshtkar, Haleh Ashraf, Faezeh Abaj, Neda Soveid, Mahya Mehri Hajmir, Mina Radmehr, Pardis Khalili & Khadijeh Mirzaei. (2024) Serum levels of trimethylamine N-oxide and kynurenine novel biomarkers are associated with adult metabolic syndrome and its components: a case-control study from the TEC cohort. Frontiers in Nutrition 11.
Crossref
Soraya Taleb. (2023) Are tryptophan metabolites new predictive biomarkers for CVD?. Atherosclerosis 387, pages 117385.
Crossref
Jianjun Hou, Shaobing Yang, Ying Guo, Ning Yan & Shaobin Jia. (2023) FUS regulates the alternative splicing of cell proliferation genes related to atherosclerosis. Experimental Biology and Medicine 248:17, pages 1459-1468.
Crossref
Tae Chung, Taylor Bopp, Chris Ward, Francesca M. Notarangelo, Robert Schwarcz, Reyhan Westbrook, Qian‐Li Xue, Jeremy Walston & Ahmet Hoke. (2023) Deletion of quinolinate phosphoribosyltransferase gene accelerates frailty phenotypes and neuromuscular decline with aging in a sex‐specific pattern. Aging Cell 22:7.
Crossref
Fengge Wang, Meng Liu, Dan Ma, Zecheng Cai, Lei Liu, Juncheng Wang, Wenjie Zhang, Lin Zhao, Chengfeng Zhai & Yuekang Xu. (2023) Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4+CD25+Foxp3+Tregs through IDO-Kyn-AHR axis. International Immunopharmacology 116, pages 109758.
Crossref
Verena Theiler-Schwetz, Christian Trummer, Martin R. Grübler, Martin H. Keppel, Armin Zittermann, Andreas Tomaschitz, Winfried März, Andreas Meinitzer & Stefan Pilz. (2023) Associations of Parameters of the Tryptophan–Kynurenine Pathway with Cardiovascular Risk Factors in Hypertensive Patients. Nutrients 15:2, pages 256.
Crossref
Reng Ren, Yuanjian FangPrativa SherchanQin LuCameron LenahanJohn H. ZhangJianmin ZhangJiping Tang. (2022) Kynurenine/Aryl Hydrocarbon Receptor Modulates Mitochondria-Mediated Oxidative Stress and Neuronal Apoptosis in Experimental Intracerebral Hemorrhage. Antioxidants & Redox Signaling 37:16-18, pages 1111-1129.
Crossref
Stein-Erik H. Solvang, Allison Hodge, Leiv Otto Watne, Otavio Cabral-Marques, Jan Erik Nordrehaug, Graham G. Giles, Pierre-Antoine Dugué, Ottar Nygård, Per Magne Ueland, Adrian McCann, Ane-Victoria Idland, Øivind Midttun, Arve Ulvik, Nathalie B. Halaas, Grethe S. Tell & Lasse M. Giil. (2022) Kynurenine Pathway Metabolites in the Blood and Cerebrospinal Fluid Are Associated with Human Aging. Oxidative Medicine and Cellular Longevity 2022, pages 1-15.
Crossref
Jost Klawitter, Matthew J. Jackson, Peter H. Smith, Katharina Hopp, Michel Chonchol, Berenice Y. Gitomer, Melissa A. Cadnapaphornchai, Uwe Christians & Jelena Klawitter. (2022) Kynurenines in polycystic kidney disease. Journal of Nephrology 36:1, pages 83-91.
Crossref
Ning Yu, Ruirui Wang, Baocheng Liu & Lei Zhang. (2022) Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research. Frontiers in Cardiovascular Medicine 9.
Crossref
Renáta Gáspár, Dóra Halmi, Virág Demján, Róbert Berkecz, Márton Pipicz & Tamás Csont. (2022) Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease. Frontiers in Immunology 12.
Crossref
Jie Yang, Ting Hao, Yu Liu, Jin Huang, Wenlei Wu, Juan Wu & Weibin Sun. (2022) Th17/Treg balance and indoleamine 2,3 dioxygenase activity in periodontitis-associated atherosclerotic patients. Journal of International Medical Research 50:2, pages 030006052210808.
Crossref
Md Jahangir Alam, Vaishnavi Puppala, Shravan K. Uppulapu, Bhabatosh Das & Sanjay K. Banerjee. 2022. Human Microbiome in Health and Disease - Part B. Human Microbiome in Health and Disease - Part B 231 279 .
Nattawut Wongpraparut, Ploy Pengchata, Sudarat Piyophirapong, Pariya Panchavinnin, Rungtiwa Pongakasira, Noppadol Arechep, Kanda Kasetsinsombat & Kittipong Maneechotesuwan. (2021) Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease. BMC Cardiovascular Disorders 21:1.
Crossref
Zhuoting Liu, Chunling Wang, Xu Wang & Ann Van Schepdael. (2021) On-line screening of indoleamine 2,3-dioxygenase 1 inhibitors by partial filling capillary electrophoresis combined with rapid polarity switching. Journal of Chromatography A 1651, pages 462305.
Crossref
Ludivine Laurans & Soraya Taleb. (2021) Métabolisme du tryptophane et interactions avec le microbiote intestinal. Cahiers de Nutrition et de Diététique 56:3, pages 154-161.
Crossref
Vetalise C Konje, Thekkelnaycke M Rajendiran, Keith Bellovich, Crystal A Gadegbeku, Debbie S Gipson, Farsad Afshinnia & Anna V Mathew. (2021) Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease. Clinical Kidney Journal 14:4, pages 1097-1105.
Crossref
Nuno R. Coelho, Clara Matos, António B. Pimpão, M. João Correia, Catarina O. Sequeira, Judit Morello, Sofia A. Pereira & Emília C. Monteiro. (2021) AHR canonical pathway: in vivo findings to support novel antihypertensive strategies. Pharmacological Research 165, pages 105407.
Crossref
Nada Joe Melhem, Mouna ChajadineIngrid GomezKiave-Yune HowangyinMarion BouvetCamille KnospYanyi SunMarie RouanetLudivine LauransOlivier Cazorla, Mathilde LemitreJosé VilarZiad Mallat, Alain TedguiHafid Ait-Oufella, Jean-Sébastien HulotJacques CallebertJean-Marie LaunayJeremy FauconnierJean-Sébastien Silvestre & Soraya Taleb. (2021) Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function After Myocardial Infarction Through Kynurenine. Circulation 143:6, pages 566-580.
Crossref
R. Baumgartner, M. Berg, L. Matic, K. P. Polyzos, M. J. Forteza, S. A. Hjorth, T. W. Schwartz, G. Paulsson‐Berne, G. K. Hansson, U. Hedin & D. F. J. Ketelhuth. (2020) Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans. Journal of Internal Medicine 289:1, pages 53-68.
Crossref
Ayse Basak Engin & Atilla Engin. 2021. Protein Kinase-mediated Decisions Between Life and Death. Protein Kinase-mediated Decisions Between Life and Death 339 356 .
Abhishek Wadhawan, Mark A. Reynolds, Hina Makkar, Alison J. Scott, Eileen Potocki, Andrew J. Hoisington, Lisa A. Brenner, Aline Dagdag, Christopher A. Lowry, Yogesh Dwivedi & Teodor T. Postolache. (2020) Periodontal Pathogens and Neuropsychiatric Health. Current Topics in Medicinal Chemistry 20:15, pages 1353-1397.
Crossref
FJH Sorgdrager, CP van Der Ley, M van Faassen, E Calus, EA Nollen, IP Kema, D van Dam & PP De Deyn. (2020) The Effect of Tryptophan 2,3-Dioxygenase Inhibition on Kynurenine Metabolism and Cognitive Function in the APP23 Mouse Model of Alzheimer’s Disease. International Journal of Tryptophan Research 13, pages 117864692097265.
Crossref
Stéphane Isnard, Rayoun Ramendra, Franck P Dupuy, John Lin, Brandon Fombuena, Nikola Kokinov, Ido Kema, Mohammad-Ali Jenabian, Bertrand Lebouché, Cecilia T Costiniuk, Petronela Ancuta, Nicole F Bernard, Michael S Silverman, Peter L Lakatos, Madeleine Durand, Cécile Tremblay, Jean-Pierre Routy, C Milne, S Lavoie, J Friedman, M Duchastel, F Villielm, F Asselin, M Boissonnault, P J Maziade, S Lavoie, M Milne, N Z Miaki, M E Thériault, B Lessard, M A Charron, S Dufresne, M E Turgeon, S Vézina, E Huchet, J P Kerba, M Poliquin, S Poulin, P Rochette, P Junod, D Longpré, R Pilarski, E Sasseville, L Charest, A Hamel, A Cloutier-Blais, S Massoud, F Chano, B Trottier, L Labrecque, C Fortin, V Hal-Gagne, M Munoz, B Deligne, V Martel-Laferrière, B Trottier, M E Goyer, M Teltscher, A de Pokomandy, J Cox, E Beauchamp, M Klein & L P Haraoui. (2020) Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus. The Journal of Infectious Diseases 221:1, pages 110-121.
Crossref
William Durante. 2020. Amino Acids in Nutrition and Health. Amino Acids in Nutrition and Health 39 56 .
Heng Liang, Mantian Chen, Fangfei Qi, Lei Shi, Zhenzhen Duan, Ruoyu Yang, Jinchao He, Bin Lou, Yigang Li & Qing Yang. (2019) The proatherosclerotic function of indoleamine 2, 3-dioxygenase 1 in the developmental stage of atherosclerosis. Signal Transduction and Targeted Therapy 4:1.
Crossref
Freek J. H. Sorgdrager, Petrus J. W. Naudé, Ido P. Kema, Ellen A. Nollen & Peter P. De Deyn. (2019) Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target. Frontiers in Immunology 10.
Crossref
Sachise KARAKAWARumi NISHIMOTOMasashi HARADANaoko ARASHIDAAkira NAKAYAMA. (2019) Simultaneous Analysis of Tryptophan and Its Metabolites in Human Plasma Using Liquid Chromatography–Electrospray Ionization Tandem Mass Spectrometry. CHROMATOGRAPHY 40:3, pages 127-133.
Crossref
Roland Baumgartner, Maria J. Forteza & Daniel F.J. Ketelhuth. (2019) The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis. Cytokine 122, pages 154148.
Crossref
Soraya Taleb. (2019) Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases. Frontiers in Immunology 10.
Crossref
Daniel F J Ketelhuth. (2019) The immunometabolic role of indoleamine 2,3-dioxygenase in atherosclerotic cardiovascular disease: immune homeostatic mechanisms in the artery wall. Cardiovascular Research 115:9, pages 1408-1415.
Crossref
Mengyu Li, Man Ki Kwok, Shirley Siu Ming Fong & Catherine Mary Schooling. (2019) Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study. Scientific Reports 9:1.
Crossref
Wang Anlu, Cai Dongcheng, Zhang He, Li Qiuyi, Zhang Yan, Qiu Yu, Xu Hao & Chen Keji. (2019) Using herbal medicine to target the “microbiota-metabolism-immunity” axis as possible therapy for cardiovascular disease. Pharmacological Research 142, pages 205-222.
Crossref
Małgorzata Szkup, Aleksander Owczarek, Anna Lubkowska, Elżbieta Chełmecka, Karolina Skonieczna-Żydecka & Elżbieta Grochans. (2019) Searching for the Role of the IFNγ rs2430561 Polymorphism in Inducible Inflammation: Contribution to Metabolic Syndrome in 45 to 60-Year-Old Women. International Journal of Environmental Research and Public Health 16:5, pages 884.
Crossref
Cori A. Cason, Kyle T. Dolan, Gaurav Sharma, Ming Tao, Rohan Kulkarni, Irene B. Helenowski, Brendan M. Doane, Michael J. Avram, Mary M. McDermott, Eugene B. Chang, C. Keith Ozaki & Karen J. Ho. (2018) Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes. Journal of Vascular Surgery 68:5, pages 1552-1562.e7.
Crossref
Yuki Watanabe, Shohei Koyama, Atsushi Yamashita, Yunosuke Matsuura, Kensaku Nishihira, Kazuo Kitamura & Yujiro Asada. (2018) Indoleamine 2,3‐dioxygenase 1 in coronary atherosclerotic plaque enhances tissue factor expression in activated macrophages. Research and Practice in Thrombosis and Haemostasis 2:4, pages 726-735.
Crossref
Qibin Qi, Simin Hua, Clary B Clish, Justin M Scott, David B Hanna, Tao Wang, Sabina A Haberlen, Sanjiv J Shah, Marshall J Glesby, Jason M Lazar, Robert D Burk, Howard N Hodis, Alan L Landay, Wendy S Post, Kathryn Anastos & Robert C Kaplan. (2018) Plasma Tryptophan-Kynurenine Metabolites Are Altered in Human Immunodeficiency Virus Infection and Associated With Progression of Carotid Artery Atherosclerosis. Clinical Infectious Diseases 67:2, pages 235-242.
Crossref
Adriano José Maia Chaves Filho, Camila Nayane Carvalho Lima, Silvânia Maria Mendes Vasconcelos, David Freitas de Lucena, Michael Maes & Danielle Macedo. (2018) IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 80, pages 234-249.
Crossref
Ji Sun Oh, Hong Seong Seo, Kyoung Heon Kim, Heesoo Pyo, Bong Chul Chung & Jeongae Lee. (2017) Urinary profiling of tryptophan and its related metabolites in patients with metabolic syndrome by liquid chromatography-electrospray ionization/mass spectrometry. Analytical and Bioanalytical Chemistry 409:23, pages 5501-5512.
Crossref
Laura V. de Vries, Isidor Minović, Casper F.M. FranssenMartijn van Faassen, Jan-Stephan F. SandersStefan P. BergerGerjan NavisIdo P. Kema & Stephan J. L. Bakker. (2017) The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation. American Journal of Physiology-Renal Physiology 313:2, pages F475-F486.
Crossref
Ping Song, Tharmarajan Ramprasath, Huan Wang & Ming-Hui Zou. (2017) Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. Cellular and Molecular Life Sciences 74:16, pages 2899-2916.
Crossref
Lysiane Boulet, Patrice Faure, Patrice Flore, Julien Montérémal & Véronique Ducros. (2017) Simultaneous determination of tryptophan and 8 metabolites in human plasma by liquid chromatography/tandem mass spectrometry. Journal of Chromatography B 1054, pages 36-43.
Crossref
Fangxuan Li, Rupeng Zhang, Shixia Li & Juntian Liu. (2017) IDO1: An important immunotherapy target in cancer treatment. International Immunopharmacology 47, pages 70-77.
Crossref
Gang Liu, Shuai Chen, Jin Zhong, Kunling Teng & Yulong Yin. (2017) Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic Implications. Oxidative Medicine and Cellular Longevity 2017, pages 1-5.
Crossref
Michael D. Lovelace, Bianca Varney, Gayathri Sundaram, Matthew J. Lennon, Chai K. Lim, Kelly Jacobs, Gilles J. Guillemin & Bruce J. Brew. (2017) Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology 112, pages 373-388.
Crossref
Mark J. Siedner, June-Ho Kim, Ruth Sentongo Nakku, Prossy Bibangambah, Linda Hemphill, Virginia A. Triant, Jessica E. Haberer, Jeffrey N. Martin, A. Rain Mocello, Yap BoumIIII, Douglas S. Kwon, Russell P. Tracy, Tricia Burdo, Yong Huang, Huyen Cao, Samson Okello, David R. Bangsberg & Peter W. Hunt. (2016) Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. Journal of Infectious Diseases 213:3, pages 370-378.
Crossref
Jennifer E. ColeNagore AstolaAdam P. CribbsMichael E. GoddardInhye ParkPatricia GreenAlun H. Davies, Richard O. WilliamsMarc FeldmannClaudia Monaco. (2015) Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. Proceedings of the National Academy of Sciences 112:42, pages 13033-13038.
Crossref
Sarvenaz Metghalchi, Padmapriya Ponnuswamy, Tabassome Simon, Yacine Haddad, Ludivine Laurans, Marc Clément, Marion Dalloz, Mélissa Romain, Bruno Esposito, Vincent Koropoulis, Bruno Lamas, Jean-Louis Paul, Yves Cottin, Salma Kotti, Patrick Bruneval, Jacques Callebert, Hester den Ruijter, Jean-Marie Launay, Nicolas Danchin, Harry Sokol, Alain Tedgui, Soraya Taleb & Ziad Mallat. (2015) Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production. Cell Metabolism 22:3, pages 460-471.
Crossref
Naghmeh Nikkheslat, Patricia A. Zunszain, Mark A. Horowitz, Izabela G. Barbosa, Jennie A. Parker, Aye-Mu Myint, Markus J. Schwarz, Andre T. Tylee, Livia A. Carvalho & Carmine M. Pariante. (2015) Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression. Brain, Behavior, and Immunity 48, pages 8-18.
Crossref
Simone J.P.M. Eussen, Per Magne Ueland, Stein E. Vollset, Ottar Nygård, Øivind Midttun, Gerhard Sulo, Arve Ulvik, Klaus Meyer, Eva Ringdal Pedersen & Grethe S. Tell. (2015) Kynurenines as predictors of acute coronary events in the Hordaland Health Study. International Journal of Cardiology 189, pages 18-24.
Crossref
Christian Murr, Tanja B. Grammer, Marcus E. Kleber, Andreas Meinitzer, Winfried März & Dietmar Fuchs. (2015) Low serum tryptophan predicts higher mortality in cardiovascular disease. European Journal of Clinical Investigation 45:3, pages 247-254.
Crossref
K. A. Polyzos & D. F. J. Ketelhuth. (2017) The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. Hämostaseologie 35:02, pages 128-136.
Crossref
Ugur Unluturk & Tomris Erbas. 2015. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease 147 171 .
Ayse Basak Engin. 2015. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease 121 145 .
Marion Sallée, Laetitia Dou, Claire Cerini, Stéphane Poitevin, Philippe Brunet & Stéphane Burtey. (2014) The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease. Toxins 6:3, pages 934-949.
Crossref
Gregory Oxenkrug. (2013) Insulin Resistance and Dysregulation of Tryptophan–Kynurenine and Kynurenine–Nicotinamide Adenine Dinucleotide Metabolic Pathways. Molecular Neurobiology 48:2, pages 294-301.
Crossref
Eva Ringdal Pedersen, Gard Frodahl Tveitevåg Svingen, Hall Schartum-Hansen, Per Magne Ueland, Marta Ebbing, Jan Erik Nordrehaug, Jannicke Igland, Reinhard Seifert, Roy Miodini Nilsen & Ottar Nygård. (2013) Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography. European Heart Journal 34:34, pages 2689-2696.
Crossref
D Theofylaktopoulou, Ø Midttun, A Ulvik, P M Ueland, G S Tell, S E Vollset, O Nygård & S J P M Eussen. (2013) A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clinical and Experimental Immunology 173:1, pages 121-130.
Crossref
. 2013. Endothelium. Endothelium 278 336 .
S. Schroecksnadel, J. Gostner, M. Jenny, K. Kurz, H. Schennach, G. Weiss & D. Fuchs. (2013) Immunomodulatory effects in vitro of vitamin K antagonist acenocoumarol. Thrombosis Research 131:6, pages e264-e269.
Crossref
Annemieke T. van der Goot & Ellen A.A. Nollen. (2013) Tryptophan metabolism: entering the field of aging and age-related pathologies. Trends in Molecular Medicine 19:6, pages 336-344.
Crossref
M. Jenny, S. Schroecksnadel, J.M. Gostner, F. Ueberall & D. Fuchs. 2013. Bioactive Food as Dietary Interventions for Cardiovascular Disease. Bioactive Food as Dietary Interventions for Cardiovascular Disease 271 281 .
Manuela Bartoli, Folami Lamoke & Babak Baban. 2013. New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM. New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM 265 282 .
Marko Elovainio, Mikko Hurme, Markus Jokela, Laura Pulkki-Råback, Mika Kivimäki, Mirka Hintsanen, Taina Hintsa, Terho Lehtimäki, Jorma Viikari, Olli T. Raitakari & Liisa Keltikangas-Järvinen. (2012) Indoleamine 2,3-Dioxygenase Activation and Depressive Symptoms. Psychosomatic Medicine 74:7, pages 675-681.
Crossref
Stephanie W. Watts, Samantha Shaw, Robert Burnett & Anne M. Dorrance. (2011) Indoleamine 2,3-diooxygenase in periaortic fat: mechanisms of inhibition of contraction. American Journal of Physiology-Heart and Circulatory Physiology 301:4, pages H1236-H1247.
Crossref
J Jylhävä, A Haarala, M Kähönen, T Lehtimäki, A Jula, L Moilanen, Y A Kesäniemi, M S Nieminen & M Hurme. (2011) Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey. Clinical and Experimental Immunology 164:2, pages 211-217.
Crossref
Michael Maes, Piyanuj Ruckoanich, Young Seun Chang, Nithi Mahanonda & Michael Berk. (2011) Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:3, pages 769-783.
Crossref
Eva Ringdal PedersenØivind MidttunPer Magne UelandHall Schartum-HansenReinhard SeifertJannicke IglandJan Erik NordrehaugMarta EbbingGard SvingenØyvind BleieRolf BergeOttar Nygård. (2011) Systemic Markers of Interferon-γ–Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 31:3, pages 698-704.
Crossref
Gregory F. Oxenkrug. (2010) Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders. Journal of Neural Transmission 118:1, pages 75-85.
Crossref
Gregory F. Oxenkrug. (2010) Metabolic syndrome, age‐associated neuroendocrine disorders, and dysregulation of tryptophan—kynurenine metabolism. Annals of the New York Academy of Sciences 1199:1, pages 1-14.
Crossref
Walter Swardfager, Nathan Herrmann, Yekta Dowlati, Paul I. Oh, Alexander Kiss, Scott E. Walker & Krista L. Lanctôt. (2009) Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease. Psychoneuroendocrinology 34:10, pages 1560-1566.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.